The role of natalizumab in hematopoietic stem cell mobilization. - Wikidata - awgldk - TriplyDB

The role of natalizumab in hematopoietic stem cell mobilization.

The role of natalizumab in hematopoietic stem cell mobilization.

http://www.wikidata.org/entity/Q37536053

about

New insights on human polyomavirus JC and pathogenesis of progressive multifocal leukoencephalopathy Bone marrow stromal cells protect lymphoma B-cells from rituximab-induced apoptosis and targeting integrin α-4-β-1 (VLA-4) with natalizumab can overcome this resistance Natalizumab exerts direct signaling capacity and supports a pro-inflammatory phenotype in some patients with multiple sclerosis Treating multiple sclerosis with monoclonal antibodies: a 2013 update.Pharmacodynamic consequences of administration of VLA-4 antagonist CDP323 to multiple sclerosis subjects: a randomized, double-blind phase 1/2 study Human polyomavirus JC replication and non-coding control region analysis in multiple sclerosis patients under natalizumab treatment.Human polyomavirus JC reactivation and pathogenetic mechanisms of progressive multifocal leukoencephalopathy and cancer in the era of monoclonal antibody therapies.Role of integrin alpha4 in drug resistance of leukemia Lymphocytosis as a response biomarker of natalizumab therapeutic efficacy in multiple sclerosis.Hematologic modifications in natalizumab-treated multiple sclerosis patients: An 18-month longitudinal study

P2860

Q26822247-E26CED1F-03F0-4B79-A47E-811A7EB38F0B Q28243054-3F0AB83B-B022-4A4D-B67D-DA375AAD81B2 Q28484467-65FB8300-C0CE-4098-827F-A813177D33EF Q34330211-3F72D863-A26C-4AC8-BF53-5C79473EE6FD Q34614995-95E7832A-AA90-4EAC-BEBF-195393F7924E Q36234246-CDD2660F-B47B-4C09-BFD2-C729820E1236 Q37980042-8E53D2DA-19F5-4A9F-85BA-8D42F7EA050A Q38218126-767CCBE1-F8BE-488D-8D07-A48E78297DD3 Q40446543-86494D2F-37F8-41D0-9D26-2598138FE76C Q42413795-DDDF1858-7D83-4C93-8173-67A66C34B2AD

P2860

The role of natalizumab in hematopoietic stem cell mobilization.

http://www.wikidata.org/entity/Q37536053

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on August 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

The role of natalizumab in hematopoietic stem cell mobilization.

@en

The role of natalizumab in hematopoietic stem cell mobilization.

@nl

type

label

The role of natalizumab in hematopoietic stem cell mobilization.

@en

The role of natalizumab in hematopoietic stem cell mobilization.

@nl

prefLabel

The role of natalizumab in hematopoietic stem cell mobilization.

@en

The role of natalizumab in hematopoietic stem cell mobilization.

@nl

P1433

Q37536053-30FD665F-0B49-44F2-9C2C-4BC0AC744020

P1476

Q37536053-6742FF74-B995-4354-A6B9-8BD20F20C8A3

P2093

Q37536053-9A77355C-7F36-4450-AD69-73DDDBEB0126

Q37536053-C89097CD-EEEE-41FD-9B48-9FC12972ADC1

Q37536053-CCEA6B32-BF20-4D54-A3E4-3370B4B270F1

P2860

Q37536053-057D2718-A4C0-478A-8282-9DEEA2368299

Q37536053-079FCF61-2A31-440D-9BE9-C408DFE468CE

Q37536053-13217760-5CB6-4153-B217-339314389A1E

Q37536053-13648DF4-F3C9-4FB9-A3F1-988890C39516

Q37536053-14CC43B9-B5AD-4631-A981-C821EA1C6E3C

Q37536053-1D4357EF-05CB-4B88-A6BE-F67232906BD5

Q37536053-230B90D8-5EE4-4B67-963D-A3FC1D62E883

Q37536053-322D2F72-B042-4613-AD5E-87F3643F50E1

Q37536053-341E6CF9-54FF-48C7-9C3D-64F1413E5ECF

Q37536053-34C550FA-F4B3-4C6C-A42E-5AB078AAFB79

P304

Q37536053-1284F81D-C185-405F-88DA-8D142AA4B864

P31

Q37536053-40394B5E-7EF7-438E-B267-4D8F6CE46E20

P356

Q37536053-E2A45BB2-4BB0-4416-9ADD-BFDB5D40BAC3

P407

Q37536053-FC172D1B-DFF7-40D8-8364-28CF594B01F7

P433

Q37536053-7A6450D5-217C-496E-BA3A-83A8F902BD98

P478

Q37536053-30604538-CC29-4206-924C-E0E10000E457

P577

Q37536053-30E29AE4-D162-43B3-9430-A56AC7BFB6FC

P698

Q37536053-78EE300B-217C-49CC-B9C9-D965E55684BA

P356

14712590903055011

P1433

Expert Opinion on Biological Therapy

P1476

The role of natalizumab in hematopoietic stem cell mobilization.

@en

P2093

Fabian Zohren

http://www.w3.org/2001/XMLSchema#string

Frank Neumann

http://www.w3.org/2001/XMLSchema#string

Rainer Haas

http://www.w3.org/2001/XMLSchema#string

P2860

Natalizumab for active Crohn's disease

Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis

Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease

A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis

AMD3100 plus G-CSF can successfully mobilize CD34+ cells from non-Hodgkin's lymphoma, Hodgkin's disease and multiple myeloma patients previously failing mobilization with chemotherapy and/or cytokine treatment: compassionate use data.

Homing and mobilization in the stem cell niche.

The VLA4/VCAM-1 adhesion pathway defines contrasting mechanisms of lodgement of transplanted murine hemopoietic progenitors between bone marrow and spleen

Anti-alpha4 integrin therapy for multiple sclerosis: mechanisms and rationale.

The use of AMD3100 plus G-CSF for autologous hematopoietic progenitor cell mobilization is superior to G-CSF alone.

The monoclonal anti-VLA-4 antibody natalizumab mobilizes CD34+ hematopoietic progenitor cells in humans.

P304

1099-1106

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14712590903055011

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P577

2009-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19566481

http://www.w3.org/2001/XMLSchema#string